AviPro Salmonella vac E, the live oral vaccine against Salmonella enteritidis made by Lohmann Animal Health, is now available in larger size vials of 5,000 doses, supplied in packs of ten. More information from: Anna-Christina Riebau, Lohmann Animal Health, Germany. Telephone: +49 (0) 4721 747 217
BCF has announced upgrades to the Easi-Scan bovine ultrasound scanner which include improved image quality and additions to the BCF Universal Googles (BUGs) range.
The BUGs range now includes a new LCD model and a monocular version. According to the company, the LCD version provides a softer, more familiar image and considerably lower price, while the monocular version is ideal for the small percentage of people that struggle to see a single image in a binocular style goggle.
John Dawson from Willows Veterinary Group, Cheshire said: "The LCD BUG has a softer image which I prefer. They give more differentiation of echogenic grading allowing more detail to be seen. When I first used them I thought they were going to be more expensive, but to get a better image at a lower price I was astonished."
Gavin Mitchell from BCF said: "These new product developments for Easi-Scan and BUGs are a great illustration of how we are committed to responding to our customers' feedback, opinions and recommendations. At BCF, we design, develop and manufacture our own equipment. It is so important to continually work closely with our customers, to continue to create world-leading ultrasound equipment."
For more information visit www.bcftechnology.com
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
The company says that CircoMax Myco offers the longest lasting combined protection on the EU market against PCV2 and M. hyopneumoniae pathogens. This reduces the PCV2 viral load in blood and lymphoid tissues, PCV2 fecal shedding, lymphoid tissue lesions associated with PCV2 infection, and lung lesions associated with M. hyopneumoniae infections.
Pig protection was demonstrated against porcine circovirus genotypes 2a, 2b and 2d and lasts for at least 23 weeks after vaccination in fattening pigs for both PCV2 and M. hyopneumoniae.
Monica Balasch, Director, Global Biologicals Development at Zoetis, said: "Porcine circovirus type 2 has demonstrated high mutation and recombination rates and is known to be rapidly evolving in Europe and worldwide. Commercial PCV2 vaccines have been efficacious in controlling the clinical disease, but there is a growing genetic gap between field viruses and vaccines. So far, all vaccines in Europe have been based on one single genotype, PCV2a, while today the most prevalent viruses found belong to other genotypes: PCV2b and especially PCV2d.
“We believe that there is a need for new vaccines, like CircoMax Myco which includes two PCV2 genotypes for a broader coverage. We found excellent results showing reduction of body weight gain losses in field trials in the EU. This innovative one-dose vaccine is a new tool for veterinarians and producers that may improve their PCV2 and M. hyopneumoniae control programs, especially in the face of multi-genotype PCV2 infections.”
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: "For many years, intensive vaccination has contributed to selective pressure and emergence of new PCV2 genotypes. European pig farms are often infected with more than one genotype and subclinical disease is frequent. Commercial vaccines are all based on PCV2a genotype while CircoMax Myco is the first vaccine that includes two PCV2 genotypes (a & b), and the inventive M. hyopneumoniae purified fraction. It is formulated with MetaStim for active immunization, resulting in 23 weeks of protection against these threats."
CircoMax Myco contains inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein and inactivated Mycoplasma hyopneumoniae, strain P-5722-3.
The British Occupational Hygiene Society (BOHS) has announced the publication of a book on controlling skin exposure and wet work. The book aims to fill a knowledge gap about dermal exposure risk management in workplaces which are particularly affected, such as veterinary practices.
The consequences of a failure to adequately control dermal exposure to hazardous agents do not always become apparent until years after exposure, and because of this, many employers are either ignorant of the consequences or ignore the potential for ill-health until it is too late. In Great Britain, over 29,000 people are suffering from work-related skin disease and every year over 3,500 new cases are reported. Alongside this, many workers are unaware of the ways in which skin comes into contact with chemicals, or how dermal exposure can contribute to inadvertent inhalation and ingestion exposure.
Healthcare workers are susceptible. Vets and nurses are, for example, at risk from disinfectants, detergents, wet-work, latex gloves, anaesthetics, antibiotics and antiseptics, phenothiazines, formaldehyde, glutaraldehyde and liquid chloroxylenol.
The book provides an introduction to the structure and functions of the skin, information about the diseases caused by dermal exposure and the occupations and chemicals involved, regulatory requirements related to dermal exposure at work, exposure and risk assessment, and risk management strategies. It is both comprehensive and accessible, and clearly illustrated with photographs, figures and tables throughout, ensuring that it will be of practical use. As a result, BOHS believes that it will make an important contribution to increasing knowledge about control of dermal exposure, and encourage more effective control measures to be introduced in workplaces.
‘Controlling Skin Exposure to Chemicals and Wet-Work' is available for £19.99 and can be purchased on-line via RMS Publishing, www.rmspublishing.co.uk/BOHS.html and Amazon, or by posting/faxing the order form which can be downloaded from the Publications section of the BOHS website.
Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.
To make ready for use, the vaccine is reconstituted by mixing a powder with sterile diluent. Once mixed, the licensed shelf life is two hours. This means any that is unused in multi-dose packs must be thrown away. By stocking a combination of one- and multi-dose packs, farmers can eliminate this.
The vaccine protects against two primary viral causes of pneumonia in young calves, BRSv and Pi3v1. Surveillance of blood samples from 2,145 calves with pneumonia signs found 78% exposed to BRSv, 81% to Pi3v2. The product licence allows use from nine days of age, with onset of immunity to BRSv and Pi3v after five and 10 days respectively. The licence also specifies a duration of immunity of 12 weeks.
Zoetis vet Carolyn Hogan says that viruses are the instigator of a majority of respiratory health problems: "Early-life protection also helps reduce the threat from opportunistic secondary bacterial infections, such as Pasteurella.
"Good respiratory health is essential to ensure calves develop to achieve their lifetime potential. But it's estimated that 67% of pneumonia cases occur in calves less than three months of age3.
"Whether suckled or reared, calves that don’t grow effectively in the early weeks are unlikely to catch up later. On both dairy and beef units, proactive management of the calf living space, nutrition and disease resilience is critical to maximise lifetime productivity, which is clearly so important under today's farm business economics.
More information about the benefits of managing respiratory health in calves is available at plantoproduce.co.uk.
Farmers within the Protection Zone (PZ) are being urged by the Joint Action against Bluetongue (JAB) to vaccinate their animals if they have not already done so.
In a joint statement JAB said: "The vaccination campaign is going exceptionally well with more than 9 million does of vaccine made available to farmers in the PZ. However, we must not be complacent, as there are still more animals to vaccinate and we must not delay in protecting them from bluetongue.
"As the weather conditions improve, the risk of new cases of bluetongue increases and the objective of the JAB campaign has been to try and protect the UK from the devastation this disease caused in much of the rest of Europe last year. We do not want to see in the UK the heavy losses of sheep seen by some other member states or the fertility problems seen in many cattle herds. The message is simple - if you want to protect your livestock, ‘don't hesitate, vaccinate'."
Commenting on the recent delays in vaccine delivery, JAB said: "It is unfortunate that we have seen a problem with the latest batch of vaccine, which for quality control reasons is undergoing further testing. JAB understands the frustration that this delay has caused. However, this is just one batch and Intervet has so far exceeded delivery expectations and we are hopeful that we will be back on track very soon."
Henry Schein said in a statement on Friday that it had sold the business in order to focus on its dental and medical markets and pursue new investment opportunities.
Covetrus says it will be using the experience, technology and global scale of the merged companies to provide veterinary practices with a more comprehensive set of integrated services and technology solutions, and tools to strengthen client relationships and grow their practice.
Covetrus launched on Nasdaq last Friday, when President and Chief Executive Officer Benjamin Shaw, said: "Today marks an important new chapter in the world of veterinary medicine, as we launch Covetrus as a new company listed on Nasdaq.
"We look forward to strengthening our customer relationships and expanding our veterinary practice partnerships worldwide as we bring more comprehensive and powerful solutions to market to meet their evolving needs and improve health and financial outcomes."
A free copy of the compendium has been sent to every veterinary practice in the UK, and it is also available online at: www.noahcompendium.co.uk. A special edition of the book commissioned by AMTRA will also be available for its SQPs shortly.
NOAH chief executive Dawn Howard said: "The NOAH Compendium, in all its formats, remains a major part of NOAH’s efforts to ensure appropriate access and responsible use of medicines for all animals. We are pleased it is even more comprehensive this year, as we continue to expand its list of contributors.
"Every NOAH member, as well as the non-member participants in the NOAH Compendium, is a signatory to the NOAH Code of Practice on Promotion, which demonstrates their commitment to operate above and beyond any regulatory requirements."
She added: “As well as product datasheets, the Compendium includes another vital resource – the contact details for each participating company. Company veterinary and technical advisors have detailed knowledge about their company’s medicines. The NOAH Code includes the requirement for NCAH qualification for NOAH staff in technical dialogue with prescribers and users of animal medicines – meaning their advice can be regarded as a valuable and trusted resource. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet."
Veterinary practices that have not yet received a copy, perhaps because they are new or have changed address in the past year should contact NOAH (noah@noah.co.uk).
Extra copies are also available to order, for £47.50. Special prices are also available for bulk orders.
Expert speakers at Advances in Diagnostics, a meeting held in Brussels last month, have said that molecular technology will play a vital role in safeguarding the health and productivity of food animals in the future.
Dr Willie Loeffen, President of the European Association of Veterinary Laboratory Diagnosticians (EAVLD) said: "Technology is taking over. Laboratory diagnosis used to be 99% labour and 1% technology, nowadays the emphasis is the other way around. Technology is now an integral and indispensable part of veterinary laboratories."
Dr Loeffen used the investigation of PRRSV infection in pigs and the more recent appearance of Schmallenberg virus in Europe to highlight how modern molecular techniques could help to characterise new disease threats rapidly.
"It took four years of laborious work for us to characterise the cause of PRRS, but thanks to sequencing technology Schmallenberg virus took just a few months.
"Technological developments mean that diagnosticians now do things that they could only dream about 10 or 20 years ago."
As well as providing a means of identifying new disease threats quickly, the meeting highlighted the increasing role of diagnostic tools as an integral part of maintaining animal health.
Dr Kirk Adams, Director of Product Management at Life Technologies, the meeting sponsor, said: "Diagnostics are no longer just a way of finding out what an animal died of - they have a multitude of uses on farm. They mean that we can take a more holistic and proactive approach to animal health; in contrast to the reactive, disease-driven approach of the past.
"As just one example, better diagnostics allow a more targeted approach to treatment, and the potential to reduce the use of broad-spectrum drugs - such as certain antibiotics - and thus comply with the wishes of consumers and legislators."
Dr Adams said that modern diagnostic tools also provided the means to improve vaccination programmes and biosecurity, and were essential for disease eradication schemes and for improving herd health status, for example by identifying persistently infected, asymptomatic animals.
They also enable veterinary surgeons to monitor herd health and build up an accurate and dynamic picture of health status and risk profile - and screen for emerging disease threats.
Dr Adams added: "Veterinarians now have access to a wider range of better diagnostics than ever before. Tests are now faster, more accurate and more precise than ever before.
"The next twenty years could see the biggest change in the way we manage production animals in over a hundred years."
The meeting was also addressed by Dr Kees van Maanen, from the Netherlands Animal health Service (GD), an expert in modern diagnostic technology and its application on both local and national levels. He called for greater international co-operation to protect European animals against threats from increasing global interaction. He said: "Pathogens and insects do not respect borders: trusting each other's results requires further harmonization and transparency for diagnostic procedures between laboratories and countries.
"Rapid and accurate diagnosis contributes to disease management, but does not stop epidemics. However, it has contributed significantly to gaining insight into the epidemiology of emerging diseases and formulating appropriate measures.
"The development of modern diagnostics has given us the potential to manage animal health and control infectious diseases in production animals far more effectively in the past - both on a local level and a national or regional level. Recent experience with unexpected disease outbreaks has shown that we can now characterise and track pathogens far more quickly and accurately than ever before.
"However, we need to make sure that we keep veterinarians and farmers informed about these developments, so they know how to apply them in practice in order to make the most of them.
"Diagnostics will continue to become a more integral part of animal health management in the next decade, we just need to make sure we can apply that knowledge in the best possible way."
Cefshot is indicated for treatment of subclinical mastitis at drying off with action against Gram positive and Gram negative bacteria.
Jude Roberts MRCVS from Zoetis says this makes possible three-way selective dry cow therapy with products from the company's dry cow portfolio: "With evidence-based triage, this covers teat sealant solo, in combination with narrow spectrum cloxacillin, or now with broader spectrum long-acting cephalonium.
"This is in keeping with the trend from milk buyers for increasing precision in the use of antibiotic dry cow therapy, and only when it is justified in the first place."
Dry periods longer that 54 days require milk withhold for 96 hours. For shorter dry periods, milk withhold is 58 days. Meat withhold period is 21 days.
Cefshot is available in multiples of 24 and 120 tubes, for delivery September onwards.
Virbac has launched of Bovigen Scour, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99).
Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum. According to the company, the vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.
Virbac says a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning. The primary course is administered in two shots, with first dose between 12 and 5 weeks before calving and the booster 3 weeks later. The annual booster is then due between 12 and 3 weeks before calving is expected. The vaccine is presented in two sizes: 15ml (5 doses) and 90ml (30 doses). The dosage per cow is 3 ml and the withdrawal time is nil in milk.
Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said: "Bovigen Scour offers farmers flexibility and ease of use. The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.
"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly. Its launch extends our large animal vaccine range, which includes Gudair, for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map)."
Hysolv Animal Health has announced that it is offering a free swine flu laboratory diagnostic service to veterinary surgeons in the UK and Ireland.
The company will supply kits to veterinary surgeons with which to take samples from pig herds they suspect are infected with swine flu. The samples, nasal swabs or blood, will be sent direct to Germany where vaccine and biological company IDT Biologika is using a special facility to detect which viruses or antibodies against certain serotypes are present.
The virological tests will be conducted by the Institute for Virus Diagnostics, part of the Federal Research Institute for Animal Health. Antibody titres against H1N1, H1N2, H3N2, panH1N1 and panH1N2 will be looked for. Hysolv says these tests, including histopathology, can provide the only conclusive proof of influenza infection.
Results from the test — which would normally cost 230 Euros (about £185) to conduct — will be available within a week. IDT is believed to be the first company offering this type of test.
According to the company, the PCR test — from nasal swabs — is much more precise than previous testing regimes and will identify and type circulating strains as well as emerging strains.
Hysolv says that when swine flu strikes a farm, the signs seen are no longer just typically flu-like but a show whole range including fever, coughing, dyspnoea as well as returns to oestrus and abortions in sows. These may be in combination and concurrent with other diseases which makes accurate diagnosis difficult.
IDT will be offering the newly-branded vaccine Respiporc Flu 3 where the veterinary surgeon feels vaccination in indicated.
Hysolv director Richard Brealey said: “IDT is raising the bar in flu testing and this is a significant advance on what has been done in the past. In 2014 one-third of 1353 nasal swabs sent for testing proved positive for swine flu in Germany. In the UK the samples will help give an insight into the epidemiological status quo of the national pig herd.”
Defra's new measures include:
Eleven additional licences for badger control covering parts of Devon, Wiltshire, Somerset, Dorset and Cheshire. Licences have been granted for supplementary badger control in areas of Gloucestershire and Somerset which have completed their original four-year licences.
The relaunch of the Badger Edge Vaccination Scheme following suspension due to a global shortage of TB vaccine, with groups invited to submit expressions of interest and feedback on the criteria for the scheme.
A new bTB Advisory Service for farmers to provide advice on-farm and by phone or email to farmers in High Risk and Edge Areas on bTB biosecurity and risk-based trading, set to launch this autumn.
Tighter control of Inconclusive Reactors (IRs) in the High Risk and Edge Area, to come into force from 1 November.
British Veterinary Association (BVA) President Gudrun Ravetz said: "Today’s announcement sees 11 new licences issued and, while BVA supports badger culling as part of a comprehensive strategy for tackling bovine TB, we will continue to call on the Government to use the targeted and humane method of cage trapping and shooting only - rather than the current method of controlled shooting.
"As one of the many tools in the toolbox, we welcome the re-commencement of the Badger Edge Vaccination Scheme, particularly if used as a ‘firebreak’ to mitigate the spread of the disease into the low risk areas. The introduction of a TB Advisory Service will provide valuable additional support for farmers, who we’d encourage to continue working with local vets on biosecurity and herd health planning.
"Yet we are concerned that Government policy seems to have moved away from the original, evidence-based proposal of a six-week time limit for badger control within the open season, which enables an intensive, coordinated and effective operation in order to secure optimum disease control benefits.
"In terms of numbers, it is clear that badger population estimates have previously demonstrated considerable uncertainty and imprecision. It is critical that as accurate as possible population estimates, using an evidence-based methodology, are obtained and made openly available.
"We would urge clarity over cull timeframes, numbers and mid-cull review methodology to ensure that the progress made, enabling the application for Officially TB Free status, is not undermined."
Today’s Defra update follows a consultation on licensed badger control conducted at the start of 2017, to which the British Veterinary Association (BVA), British Veterinary Zoological Society (BVZS) and the Association of Government Veterinarians (AGV) submitted a formal, joint response.
Photo: Young Eurasian Badger (Meles Meles), by BadgerHero, CC BY-SA 3.0
DairyCo has announced the launch of a new programme designed to tackle the challenge of lameness on dairy farms.
The Healthy Feet Programme has been developed to provide a structured approach to assist vets and foot trimmers to work more closely with their farmer clients, to reduce the incidence of lameness on a permanent basis.
DairyCo product manager, Kate Cross said: "We've developed the programme to build on the DairyCo Mobility Score by introducing a programme that dairy farmers can undertake working with their vet who is a trained 'mobility mentor', to identify problems, risk factors and suitable intervention strategies on the farm. An action plan is then agreed to prioritise management practices that have a permanent impact on incidence of lameness."
The programme draws on the findings from the Bristol Healthy Feet Project, the New Zealand Healthy Hooves programme, First Steps and Claw Signals. As well as the valuable experience gained from the DairyCo mastitis plan. It has been designed to combine the best features of all these programmes and aims to build on the successful DairyCo Mobility Score.
Vets are invited to enrol for a two day CPD course, which will enable them to introduce the Healthy Feet Programme to their farmer clients and provide on-going support, assisted by a range of resources provided by DairyCo.
The first course is scheduled for June 2011
For further details please contact Kate Cross on 02476 478686 or email healthyfeet@dairyco.ahdb.org.uk
In the study, the Pirbright - Wageningen research team combined their expertise in both FMDV and mathematical modelling to evaluate the methods and effects of preclinical diagnosis during surveillance (as would be in place during an outbreak), in order to reduce the risk of transmission between herds of cattle on neighbouring farms.
Transmission experiments in cattle were used to collect samples taken from individual animals such as blood, saliva and nasal swabs, and at herd level such as air samples, on a daily basis during the course of infection. The sensitivity of each of these types of samples for the detection of infected cattle during different phases of infection was then quantified.
Dr. Simon Gubbins, Head of Transmission Biology at Pirbright said: "Our results were incorporated into a mathematical model for FMDV transmission in a cattle herd in order to evaluate the impact of early detection and removal of an infected herd on the reduction in the amount of infectious output which could enable transmission of the virus to cattle on a neighbouring farm.
"By using weekly surveillance, clinical inspection alone was found to be ineffective at blocking transmission. This was in contrast to the impact of weekly sampling using saliva swabs of at least ten animals per farm or daily air sampling (for housed cattle), both of which were shown to reduce the risk of transmission substantially."
Dr. José Gonzáles from Wageningen Bioveterinary Research added: "These findings provide a new approach to disease control which could be added to our emergency preparedness programmes. A potential benefit of applying this strategy is a reduction in the number of animals culled unnecessarily, which is likely to happen when traditional strategies such as pre-emptive culling are implemented."
Following these initial results, the Pirbright - Wageningen research team plan to take their approach from the controlled conditions of the laboratory and test it in field trials. If successful, they hope it will help to reduce the social and economic impact of one of the world’s most devastating livestock diseases.
The plans developed by the Animal and Plant Health Agency (APHA), an agency of the Department for Environment, Food & Rural Affairs (DEFRA), involved the creation of a new role of Certification Support Officers (CSOs), non-veterinarians who would support the work of Official Veterinarians (OVs) in the signing of export health certificates for products of animal origin such as meat, dairy, processed products and animal by-products.
The proposals for the creation of CSOs by APHA has arisen due to concerns about the growth of exports in recent years and the potential for an up to 300% increase in products requiring OV certification if the UK has to certify exports of products of animal origin to the EU once the UK leaves the EU. Under APHA’s plans CSOs will work under the direction of veterinary surgeons and support their certification work (for example, verifying temperature checks), although the final certification will always need to be signed by OVs. The role will not involve certification relating to live animals or germinal products.
At the RCVS Council meeting on Thursday 1 November 2018 Council members agreed to facilitate APHA’s proposals and to make changes to the RCVS requirements so as to allow CSOs to support OVs in their certification work.
Amanda Boag, RCVS President, said: "As we have stated in our recent statement on ‘no-deal’ Brexit, it has been estimated that there would be 325% increase in veterinary certification requirements if the UK leaves the EU without a deal, and with these proposals Defra and APHA are preparing for this by increasing the support available for Official Veterinarians. Furthermore the proposal is in line with the concept of a vet-led team, with veterinary surgeons focusing on tasks only vets can do, whilst delegating some tasks to suitably trained and quality-assured members of our teams.
"We appreciate that there were some concerns over the level of education and training required by CSOs and are glad that the APHA has accommodated those views by increasing the level of education to three A-Levels (or equivalent in Scotland) and clarifying the nature of the training required by CSOs.
"By signalling its support for the proposals, RCVS Council has been assured that the integrity and value of the veterinary signature will be upheld and we are glad that we can play a key role in helping the veterinary profession prepare the UK for leaving the EU."
The RCVS position statement on the potential impact of a ‘no-deal’ Brexit scenario is available at www.rcvs.org.uk/brexit
BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
Ceva Animal Health has produced a new advisory leaflet about enzootic abortion control and vaccination strategy in sheep to help vets explain the best prevention protocols to clients.
According to the company, it is estimated that around half of the 400,000 infectious abortions in UK sheep each year are from enzootic abortion caused by Chlamydophila abortus, but timely vaccination programmes can prevent such dramatic losses.
The eight-page leaflet explains how enzootic abortion can spread, why prevention is better than cure, the importance of timely vaccination of ewe lambs and replacement stock, how vaccination programmes make good economic sense and the benefits of using Cevac Chlamydia, Ceva Animal Health's live enzootic abortion vaccine as part of the control programme.
Carol Atkinson, reprodAction's product manager said: "Cevac Chlamydia receives consistently good feedback from vets, many of whom have enthusiastically volunteered their praise for the product to our territory managers. We thought a leaflet would be a constructive way to share views, giving vets the chance to hear about the advantages of vaccination and to provide them with the tools to explain to their clients why vaccinating against enzootic abortion is cost worthy."
For further information contact Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Dechra Veterinary Products has launched Cyclo Spray, an antibiotic spray for veterinary professionals treating hard to reach sites when handling cattle, sheep and pigs.
Dechra says the new product has been developed for use at any angle, even upside down.
Cyclo Spray (chlortetracycline hydrochloride 2.45%) is indicated for the treatment of superficial claw and hoof infections and the prevention of infections of superficial traumatic or surgical wounds.
Dechra Veterinary Products Brand Manager Emma Jennings said: "Vets dealing with livestock can often find that they are twisting themselves into awkward positions to get to hard to reach sites with traditional spray can treatments. Not only are they having to find the right angle to ensure the can works, but also potentially the treatment can drip or take time to dry.
"We've introduced Cyclo Spray to our portfolio to help combat some of those difficulties - it is a new 360 degree spray can allowing users to mark the site of application with confidence from whatever angle. It is non-drip, fast-drying with excellent adhesive characteristics and contains a non-toxic colouring agent."
Cyclo Spray is available in 211ml and 422ml can sizes. No withdrawal days are required for meat and milk.
To promote the launch of the new product, Dechra has also launched a competition giving entrants the chance to win a two day trip to London for two people to ride the London Eye and experience the capital from a 360 degree vantage point.
To enter the competition, with the prize including return rail travel, and dinner, bed and breakfast in a 4* hotel, visit www.dechra.co.uk to download an entry form.
Virbac has announced that its recently launched parasiticide Neoprinil has been granted a shelf life extension from one to two years after first opening.
The company says the extension will help minimise the risk of wasted product and increase its convenience to farmers.
An eprinomectin pour-on solution, Neoprinil is indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles. It is administered using the company's Farmpack and Flexibag, and offers a zero-day withdrawal period in milk.
Virbac's Product Manager for Large Animals Brigitte Goasduf MRCVS said: "Understanding the challenges our customers face and offering products to overcome them is our goal so we are delighted that Neoprinil has received a shelf life extension because this adds to its flexibility and convenience for farmers. It also brings it into line with Deltanil, our deltamethrin-based pour-on for use against a range of ectoparasites in cattle and sheep.
"We now offer a comprehensive and flexible parasiticide range administered with a dispensing system that sets a new standard for convenience and ease of use."
Neoprinil is presented in 2.5l, 4.5l and 8l pack sizes.
Each week, the email will cover a different topic concerning either dairy, beef, sheep, pigs, poultry or gamebirds. The information, which is personalised with the practice details, can then be forwarded to clients who have an interest in that particular area, for example a resource on mastitis could be sent to dairy farmers and their staff.
Mike Howe, Veterinary Director at NADIS said: "We are confident that practices will recognise the value of the NADIS material and utilise this free service, as it will not only help to raise disease awareness, but will also assist vets in encouraging farmers to think about optimising their herd health. All NADIS materials promote veterinary health planning as the most effective way of preventing disease, and promote the vet’s role on the farm."
The resources also offer an opportunity for farmers and their staff to gain a City & Guilds unit of accreditation. A module can be completed by passing all the quizzes from each disease resource, providing an easy and flexible way for farmers and farm employees to gain recognised qualifications.
For more information, visit: www.nadis.org.uk.
Intervet/Schering-Plough Animal Health has produced a new medicine record book to help producers effectively document animal health product usage, to coincide with the cattle pneumonia season.
The Resflor-sponsored booklet incorporates space to record all the necessary information to comply with legislative requirements.
Intervet/Schering-Plough livestock veterinary adviser Paul Williams MRCVS said: "If you are in the business of rearing, producing or treating farm animals that will end up as food for human consumption, you must keep a record of any veterinary medicinal product you give or treat them with.
"You must also keep proof of purchase of all veterinary medicinal products and keep all your records for a period of five years. A format for keeping all these records is set out in this book."
To order Resflor medicine record books to give your clients, ring: 01694 731777
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".